Norway· NO-ID_E63881E3-3F58-43FD-B9DB-A19E16889C39
Cytarabin Fresenius Kabi
A cytarabine product containing cytarabine, registered in Norway by Fresenius Kabi Norge AS. The same ATC class is registered in 16 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Cytarabine is registered in 16 of 19 countries.
Countries holding a registration under ATC L01BC01 (cytarabine), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 9 of them publish a price we can compare per daily dose
Cytarabine · ATC L01BC01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Cytarabine
- Manufacturer
- Fresenius Kabi Norge AS
- Country
- Norway (NO)
- ATC code
- L01BC01
- ATC class
- Cytarabine
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- October 2, 2026
Packs & prices · 5
2 priced- no_varenummer52775510NOK 316.5
- no_merkevare_idID_E63881E3-3F58-43FD-B9DB-A19E16889C39
- no_varenummer46298720NOK 596.9
- gtin4052682022111
- gtin4052682022104
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
415 interactions on record for cytarabine.
Graded by severity as the source publishes them — 35 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cytarabine · interactions on record
415 records
- 35 severe
- 113 moderate
- 16 minor
- 251 info
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- CladribineL01BB04severe
- PexidartinibL01EX15severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cytarabine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumCytarabine Accord Healthcare 100 mg/mlAccord Healthcare
- CzechiaCYTARABINE ACCORDACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava
- IrelandCytarabine 100 mg/ml solution for injectionPfizer Healthcare Ireland Unlimited Company
- SwedenCytarabin Fresenius Kabi 100 mg/ml Injektions-/infusionsvätska, lösningFresenius Kabi AB
- FinlandArabineHospira Nordic AB
- PolandCytarabine KabiFresenius Kabi Polska Sp. z o.o.
- SpainCITARABINA ACCORD 100 mg/ml SOLUCION INYECTABLE Y PARA PERFUSIONAccord Healthcare S.L.U.
- IcelandCytarabin Fresenius KabiFresenius Kabi AB
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Alexan, Cytarabin Accord
- Belgium · Cytarabine Accord Healthcare, Cytarabine Fresenius Kabi
- Bulgaria · Алексан, Цитарабин Акорд
- Cyprus · Cytarabine Accord, Cytarabine Pfizer Hellas
- Czechia · Alexan, Cytarabine Accord
- Germany · Ara-Cell, Cytarabin Accord
- Denmark · Cytarabin Fresenius Kabi, Cytarabine Accord
- Estonia · Cytarabine Accord, Cytarabine Kabi
- Spain · Citarabina Accord, Citarabina Kabi
- Finland · Cytarabine Accord, Cytarabine Accord Healthcare
- France · Aracytine, Cytarabine Accord
- United Kingdom (Northern Ireland) · Cytarabine Accord Healthcare, Cytarabine Fresenius Kabi Oncology
- Greece · Aracytin, Citabion
- Croatia · Cytosar
- Hungary · Alexan, Cytarabine Accord
- Ireland · Cytarabine, Cytarabine Accord Healthcare Ireland
- Iceland · Cytarabin Fresenius Kabi, Cytarabine Pfizer
- Italy · Aracytin, Citarabina Accord
- Lithuania · Cytarabine Accord, Cytarabine Kabi
- Luxembourg · Cytosar
- Latvia · Cytarabine Accord, Cytarabine Kabi
- Malta · Cytarabine Accord Healthcare, Cytarabine Pfizer Hellas
- Netherlands · Cytarabine Accord, Cytarabine Fresenius Kabi
- Poland · Alexan, Cytarabina Accord
- Portugal · Citaloxan, Citarabina Accord
- Romania · Citarabină Accord, Citarabina Kabi
- Sweden · Cytarabin Fresenius Kabi, Cytarabin Hikma
- Slovenia · Citarabin Accord, Cytosar
- Slovakia · Cytarabine Accord, Cytosar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4f585f72-f4f8-4153-a5e1-f59641f0ff3d GET /v1/drugs/4f585f72-f4f8-4153-a5e1-f59641f0ff3d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Injeksjons-/infusjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Cytarabin",
"merkevare_id": "ID_E63881E3-3F58-43FD-B9DB-A19E16889C39",
"name_form_strength": "Cytarabin Fresenius Kabi inj/inf, oppl 100 mg/ml",
"prescription_group": "C"
}See everything about cytarabine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.